Page last updated: 2024-11-04

salophen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

salophen: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

salphen: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1984
CHEMBL ID92590
CHEBI ID135115
SCHEMBL ID25220
MeSH IDM0238916
PubMed CID221227
CHEMBL ID1985188
CHEMBL ID2238551
SCHEMBL ID710476
SCHEMBL ID710477
MeSH IDM0238916

Synonyms (127)

Synonym
CHEMBL92590
nsc-757877
phenetsal
KBIO1_000629
DIVK1C_000629
SPECTRUM_000157
SPECTRUM5_001149
acetaminosalol
IDI1_000629
NCGC00094917-02
NCGC00094917-01
KBIOGR_001589
KBIO2_003205
KBIO2_005773
KBIOSS_000637
KBIO3_001972
KBIO2_000637
SPECTRUM3_000936
NINDS_000629
SPBIO_001562
SPECTRUM2_001431
SPECTRUM4_001035
SPECTRUM1501170
CHEBI:135115
HMS501P11
HMS1921L21
(4-acetamidophenyl) 2-hydroxybenzoate
4-acetamidophenyl 2-hydroxybenzoate
4'-hydroxyacetanilide salicylate
4-acetylaminophenyl salicylat
acetaminosalolum [inn-latin]
acetaminosalolum
unii-o3j7h54kmd
2-hydroxybenzoic acid, 4-(acetylamino)phenyl-, ester
4-hydroxyacetanilide salicylate
acetaminosalolo [dcit]
salophen
nsc 757877
acetaminosalol [inn:dcf]
einecs 204-261-3
acetaminosalolo
4-(acetylamino)phenyl salicylate
o3j7h54kmd ,
118-57-0
nsc757877
pharmakon1600-01501170
tox21_111357
dtxcid5025865
cas-118-57-0
dtxsid7045865 ,
CCG-38983
acetaminosalol [inci]
acetaminosalol [who-dd]
acetaminosalol [inn]
acetaminosalol [mi]
acetaminosalol [mart.]
AKOS022179581
SCHEMBL25220
4-acetaminophenylsalicylate
salofena
cetosal
p-acetylaminophenyl salicylate
TWIIVLKQFJBFPW-UHFFFAOYSA-N
4-acetamidophenyl salicylate
cetosalol
benzoic acid, 2-hydroxy-, 4-(acetylamino)phenyl ester
phenestal
p-acetamidophenyl salicylate
salicylic acid p-acetylaminophenyl ester
4-(acetylamino)phenyl salicylate #
salicylic acid, ester with 4'-hydroxyacetanilide
asalphen
phenosol
AB00052232_02
2-hydroxybenzoic acid 4-(acetylamino)phenyl ester
sr-01000872767
SR-01000872767-1
4-acetylaminophenyl-2-hydroxybenzoate
SBI-0051670.P002
Q4673251
2-hydroxybenzoicacid4-(acetylamino)phenylester
acetyl-p-aminophenylsalicylate
BRD-K58464880-001-02-5
4-acetamidophenyl2-hydroxybenzoate
CBDIVE_015223
n,n'-(o-phenylene)bis(salicylideneamine)
phenol,2'-[1,2-phenylenebis(nitrilomethylidyne)]bis-
nsc5478
bis(salicylidene)-o-phenylenediamine
o-cresol,.alpha.'-(o-phenylenedinitrilo)di-
3946-91-6
nsc-5478
2-[(e)-[2-[(e)-(2-hydroxyphenyl)methyleneamino]phenyl]iminomethyl]phenol
2-(((2-((2-hydroxybenzylidene)amino)phenyl)imino)methyl)phenol
NCI60_017653
nsc-650732
nsc650732
n,n'-bis(salicylidene)-1,2-phenylenediamine, 97%
n,n'-disalicylal-1,2-phenylenediamine
D2572
n,n'-bis(2-hydroxybenzylidene)-1,2-phenylenediamine
n,n'-bis(salicylidene)-1,2-phenylenediamine
AKOS003624069
2,2'-{benzene-1,2-diylbis[nitrilo(e)methylylidene]}diphenol
STK069432
6-[[2-[(6-oxocyclohexa-2,4-dien-1-ylidene)methylamino]anilino]methylidene]cyclohexa-2,4-dien-1-one
2,2'-((1,2-phenylenebis(azanylylidene))bis(methanylylidene))diphenol
A824561
FT-0635070
CHEMBL1985188 ,
SCHEMBL710476
SCHEMBL710477
CHEMBL2238551
mfcd00009995
salphen
1,2-bis-(2-oxybenzylidenamino) -benzene
n,n'-bis(salicylidene)-o-phenylenediamine
2-[[2-[(2-hydroxyphenyl)methylideneamino]phenyl]iminomethyl]phenol
bdbm50494678
MGJWLVOAKUZEGP-UHFFFAOYSA-N
AS-10611
2,2'-(1e,1'e)-(1,2-phenylenebis(azan-1-yl-1-ylidene))bis(methan-1-yl-1-ylidene)diphenol
D90085
n,n-disalicylal-1,2-phenylenediamine
CS-0086477
SY009691
n,n inverted exclamation mark -bis(salicylidene)-1,2-phenylenediamine

Research Excerpts

Overview

Zn-salophen complexes are a promising class of fluorescent chemosensors for nucleotides and nucleic acids.

ExcerptReferenceRelevance
"Zn-salophen complexes are a promising class of fluorescent chemosensors for nucleotides and nucleic acids. "( Excited state dynamics of Zn-salophen complexes.
Bodo, E; Catone, D; Dalla Cort, A; O'Keeffe, P; Paladini, A; Piccirillo, S; Turchini, S, 2022
)
1.63

Effects

ExcerptReferenceRelevance
"A Zn-salophen complex has been incorporated into POPC large unilamellar liposomes (LUV) obtained in phosphate buffer at pH 7.4. "( Kinetics of demetallation of a zinc-salophen complex into liposomes.
Angelini, G; Cort, AD; De Maria, P; Fontana, A; Gasbarri, C; Giannicchi, I; Siani, G, 2012
)
1.17

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbonyl compoundAny compound containing the carbonyl group, C=O. The term is commonly used in the restricted sense of aldehydes and ketones, although it actually includes carboxylic acids and derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency25.11890.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency25.11890.025120.237639.8107AID893
LuciferasePhotinus pyralis (common eastern firefly)Potency25.57480.007215.758889.3584AID624030
TDP1 proteinHomo sapiens (human)Potency10.85820.000811.382244.6684AID686978; AID686979
AR proteinHomo sapiens (human)Potency23.91450.000221.22318,912.5098AID743036
estrogen nuclear receptor alphaHomo sapiens (human)Potency25.24720.000229.305416,493.5996AID743075; AID743079
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency25.11890.001815.663839.8107AID894
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Ki1.17000.00021.10439.9000AID1058080
Carbonic anhydrase 1Homo sapiens (human)Ki100.00000.00001.372610.0000AID1058083
Carbonic anhydrase 2Homo sapiens (human)Ki3.42000.00000.72369.9200AID1058082
Carbonic anhydrase 9Homo sapiens (human)Ki2.45000.00010.78749.9000AID1058081
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID227700Anticonvulsant activity2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1058080Inhibition of human recombinant carbonic anhydrase 12-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
AID1058081Inhibition of human recombinant carbonic anhydrase 9-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
AID1058083Inhibition of human recombinant carbonic anhydrase 1-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
AID1058082Inhibition of human recombinant carbonic anhydrase 2-mediated CO2 hydration preincubated for 15 mins by stopped-flow assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (116)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (0.86)18.2507
2000's30 (25.86)29.6817
2010's69 (59.48)24.3611
2020's16 (13.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.12 (24.57)
Research Supply Index4.39 (2.92)
Research Growth Index5.77 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews2 (2.50%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other78 (97.50%)84.16%
Other36 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]